Gepotidacin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications
Characterization of gepotidacin activity, including in vitro kill kinetics, checkerboard, and PAE/SME testing against gram-positive and gram-negative bacteria.
Journal: Microbiology spectrum
Published: August 06, 2026
Comparative efficacy of oral antibiotics against intracellular populations of uropathogenic Escherichia coli and bladder cell inflammatory response.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: July 28, 2026
In vitro evaluation of the activity of pairwise combinations of zoliflodacin, gepotidacin, and ciprofloxacin against Neisseria gonorrhoeae.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026
Gepotidacin in oral antibacterial pharmacotherapy: efficacy, safety, and clinical positioning.
Journal: Expert opinion on pharmacotherapy
Published: July 15, 2026
Safety and efficacy of gepotidacin in urinary tract infection: a GRADE-assessed systematic review and meta-analysis-right-to-reply.
Journal: The Journal of antimicrobial chemotherapy
Published: July 09, 2026
The changing picture of community acquired urinary tract infections in the US: a daunting prospect.
Journal: Expert review of anti-infective therapy
Published: July 06, 2026
In vitro antibacterial activity of gepotidacin in combination with other antimicrobial agents against Neisseria gonorrhoeae isolates.
Journal: Antimicrobial agents and chemotherapy
Published: July 02, 2026
Oral Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: Nucleic Acid Amplification Testing Outcomes in a Randomized, Multicenter Phase 3 Trial (EAGLE-1).
Journal: Open forum infectious diseases
Published: June 18, 2026
Antibiotic Stewardship in Pediatric Urinary Tract Infections: Current Evidence and Practical Strategies.
Journal: Antibiotics (Basel, Switzerland)
Published: June 01, 2026
Extensively drug-resistant (XDR) Neisseria gonorrhoeae cured with ceftriaxone 2 g intravenous monotherapy in Croatia, March 2026.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: May 29, 2026
Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018-23.
Journal: The Journal of antimicrobial chemotherapy
Published: May 21, 2026
Sulopenem Etzadroxil/Probenecid: A Comprehensive Review of an Oral Thiopenem.
Journal: The Annals of pharmacotherapy
Published: May 15, 2026
Last Updated: 09/26/2026